Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 attack rate and population immunity in southern New England, March 2020 - May 2021

Thu Nguyen-Anh Tran, Nathan B Wikle, Fuhan Yang, Haider Inam, Scott Leighow, Bethany Gentilesco, Philip Chan, Emmy Albert, Emily R Strong, Justin R Pritchard, William P Hanage, Ephraim M Hanks, Forrest W. Crawford, View ORCID ProfileMaciej F Boni
doi: https://doi.org/10.1101/2021.12.06.21267375
Thu Nguyen-Anh Tran
1Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan B Wikle
2Center for Infectious Disease Dynamics, Department of Statistics, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fuhan Yang
1Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haider Inam
3Center for Infectious Disease Dynamics, Department of Bioengineering, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Leighow
3Center for Infectious Disease Dynamics, Department of Bioengineering, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bethany Gentilesco
4Department of Medicine, Brown University, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Chan
4Department of Medicine, Brown University, Providence, RI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmy Albert
5Department of Physics, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily R Strong
2Center for Infectious Disease Dynamics, Department of Statistics, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin R Pritchard
3Center for Infectious Disease Dynamics, Department of Bioengineering, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William P Hanage
6Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ephraim M Hanks
2Center for Infectious Disease Dynamics, Department of Statistics, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Forrest W. Crawford
7Department of Biostatistics, Yale Schools of Public Health, Yale University, New Haven, CT
8Department of Biostatistics, Yale Schools of Public Health, Yale University, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maciej F Boni
1Center for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maciej F Boni
  • For correspondence: mfb9@psu.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Estimating an infectious disease attack rate requires inference on the number of reported symptomatic cases of a disease, the number of unreported symptomatic cases, and the number of asymptomatic infections. Population-level immunity can then be estimated as the attack rate plus the number of vaccine recipients who had not been previously infected; this requires an estimate of the fraction of vaccines that were distributed to seropositive individuals. To estimate attack rates and population immunity in southern New England, we fit a validated dynamic epidemiological model to case, clinical, and death data streams reported by Rhode Island, Massachusetts, and Connecticut for the first 15 months of the COVID-19 pandemic, from March 1 2020 to May 31 2021. This period includes the initial spring 2020 wave, the major winter wave of 2020-2021, and the lagging wave of lineage B.1.1.7(Alpha) infections during March-April 2021. In autumn 2020, SARS-CoV-2 population immunity (equal to the attack rate at that point) in southern New England was still below 15%, setting the stage for a large winter wave. After the roll-out of vaccines in early 2021, population immunity in many states was expected to approach 70% by spring 2021, with more than half of this immune population coming from vaccinations. Our population immunity estimates for May 31 2021 are 73.4% (95% CrI: 72.9% - 74.1%) for Rhode Island, 64.1% (95% CrI: 64.0% - 64.4%) for Connecticut, and 66.3% (95% CrI: 65.9% - 66.9%) for Massachusetts, indicating that >33% of southern Englanders were still susceptible to infection when the Delta variant began spreading in July 2021. Despite high vaccine coverage in these states, population immunity in summer 2021 was lower than planned due to 34% (Rhode Island), 25% (Connecticut), and 28% (Massachusetts) of vaccine distribution going to seropositive individuals. Future emergency-setting vaccination planning will likely have to consider over-vaccination as a strategy to ensure that high levels of population immunity are reached during the course of an ongoing epidemic.

Competing Interest Statement

W.P.H. serves on the Scientific Advisory Board of Biobot Analytics. W.P.H. has provided expert witness testimony on the expected course of the pandemic. M.F.B. has received consulting fees from for-profit companies on the current state and likely future of the COVID-19 pandemic.

Funding Statement

M.F.B., T.N-A.T. are funded by a grant from the Bill and Melinda Gates Foundation (INV-005517). F.Y. is supported by the NIH/NIAID Center of Excellence in Influenza Research and Surveillance contract HHS N272201400007C. K.B. was partially supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R35GM133700. W.P.H. is funded by an award from the NIGMS (U54 GM088558). E.A. is funded by the Penn State MRSEC, Center for Nanoscale Science, NSF DMR-1420620. E.M.H. was partially supported by NSF DMS-2015273. F.W.C is supported by Cooperative Agreement 6NU50CK000524-01 from the Centers for Disease Control and Prevention, funds from the COVID-19 Paycheck Protection Program and Health Care Enhancement Act, NIH/NICHD Grant 1DP2HD091799-01, and the Pershing Square Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study involves only openly available human data, which can be obtained from: https://github.com/bonilab/covid19-attackrate-RI-MA-CT

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data and code are available at https://github.com/bonilab/covid19-attackrate-RI-MA-CT

https://github.com/bonilab/covid19-attackrate-RI-MA-CT

https://www.medrxiv.org/content/medrxiv/early/2021/08/18/2020.11.17.20232918/DC1/embed/media-1.pdf?download=true

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 attack rate and population immunity in southern New England, March 2020 - May 2021
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 attack rate and population immunity in southern New England, March 2020 - May 2021
Thu Nguyen-Anh Tran, Nathan B Wikle, Fuhan Yang, Haider Inam, Scott Leighow, Bethany Gentilesco, Philip Chan, Emmy Albert, Emily R Strong, Justin R Pritchard, William P Hanage, Ephraim M Hanks, Forrest W. Crawford, Maciej F Boni
medRxiv 2021.12.06.21267375; doi: https://doi.org/10.1101/2021.12.06.21267375
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 attack rate and population immunity in southern New England, March 2020 - May 2021
Thu Nguyen-Anh Tran, Nathan B Wikle, Fuhan Yang, Haider Inam, Scott Leighow, Bethany Gentilesco, Philip Chan, Emmy Albert, Emily R Strong, Justin R Pritchard, William P Hanage, Ephraim M Hanks, Forrest W. Crawford, Maciej F Boni
medRxiv 2021.12.06.21267375; doi: https://doi.org/10.1101/2021.12.06.21267375

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9785)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2319)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11657)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2149)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4674)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)